Our top pick for
Beginners
Finder Award
Homology Medicines Inc is a biotechnology business based in the US. Homology Medicines shares (FIXX) are listed on the NASDAQ and all prices are listed in US Dollars. Homology Medicines employs 224 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Homology Medicines
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FIXX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Homology Medicines stock price (NASDAQ: FIXX)
Use our graph to track the performance of FIXX stocks over time.Homology Medicines shares at a glance
Information last updated 2022-06-25.
| Latest market close | $1.97 |
|---|---|
| 52-week range | $1.30 - $8.90 |
| 50-day moving average | $1.77 |
| 200-day moving average | $3.99 |
| Wall St. target price | $11.64 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.05 |
Buy Homology Medicines shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 6 of 6
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Homology Medicines stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Homology Medicines price performance over time
Historical closes compared with the close of $1.97 from 2022-06-29
| 1 week (2022-06-23) | -12.44% |
|---|---|
| 1 month (2022-05-26) | N/A |
| 3 months (2022-03-26) | N/A |
| 6 months (2021-12-26) | N/A |
| 1 year (2021-06-30) | -72.90% |
|---|---|
| 2 years (2020-06-30) | -87.03% |
| 3 years (2019-06-28) | 19.57 |
| 5 years (2017-06-26) | N/A |
Homology Medicines financials
| Revenue TTM | $5.5 million |
|---|---|
| Gross profit TTM | $-59,114,000 |
| Return on assets TTM | -30.34% |
| Return on equity TTM | -1.11% |
| Profit margin | -47.29% |
| Book value | $4.64 |
| Market capitalisation | $116.5 million |
TTM: trailing 12 months
Homology Medicines share dividends
We're not expecting Homology Medicines to pay a dividend over the next 12 months.
Homology Medicines share price volatility
Over the last 12 months, Homology Medicines's shares have ranged in value from as little as $1.3 up to $8.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Homology Medicines's is -0.2141. This would suggest that Homology Medicines's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Homology Medicines has bucked the trend.
Homology Medicines overview
Homology Medicines, Inc. , a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc.
Frequently asked questions
What percentage of Homology Medicines is owned by insiders or institutions?Currently 9.148% of Homology Medicines shares are held by insiders and 61.83% by institutions. How many people work for Homology Medicines?
Latest data suggests 224 work at Homology Medicines. When does the fiscal year end for Homology Medicines?
Homology Medicines's fiscal year ends in December. Where is Homology Medicines based?
Homology Medicines's address is: One Patriots Park, Bedford, MA, United States, 01730 What is Homology Medicines's ISIN number?
Homology Medicines's international securities identification number is: US4380831077 What is Homology Medicines's CUSIP number?
Homology Medicines's Committee on Uniform Securities Identification Procedures number is: 438083107
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert